AGIO Stock Analysis: Buy, Sell, or Hold?
AGIO - Agios Pharmaceuticals, Inc.
$27.44
-0.17 (-0.62%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 12, 2026
10d
Get Alerted When AGIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AGIO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: AGIO shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: AGIO is currently trading at $27.44, which is considered fair relative to its 30-day fair value range of $26.87 to $28.70.
Technical Outlook: Technically, AGIO is in a strong downtrend. Immediate support is located at $26.25, while resistance sits at $29.93.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (13th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $36.75 (+33.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AGIO is in a strong downtrend. Immediate support is located at $26.25, while resistance sits at $29.93.
Market Sentiment: AGIO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (13th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $36.75 (+33.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$26.87 -
$28.70
Company Quality Score
50/100
(HOLD)
Options IV Signal
13th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 13th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 33.9% below Wall St target ($36.75)
Fair Price Analysis
30-Day Fair Range
$26.87 -
$28.70
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$2.76
(10.1%)
Support & Resistance Levels
Support Level
$26.25
Resistance Level
$29.93
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.16
Wall Street Target
$36.75
(+33.9%)
Revenue Growth (YoY)
43.7%
Last updated: January 31, 2026 9:18 PM ET
Data refreshes hourly during market hours. Next update: 10:18 PM
Data refreshes hourly during market hours. Next update: 10:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AGIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
David Scadden
SELL
200 shares
2025-10-08
Cecilia Jones
SELL
3651 shares
2025-09-26
Theodore James Jr. Washb…
SELL
8546 shares
2025-09-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$42 | 64 BUY |
Advanced AGIO Option Strategies
Professional options setups generated by AI based on today's AGIO price and gamma walls.
